FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutics, namely a pharmaceutical composition for intranasal application for treating inflammatory and allergic diseases. Pharmaceutical composition contains fexofenadine hydrochloride, ammonium glycyrrhizinate, benzalkonium chloride, sodium hydroxide and purified water in a certain ratio.
EFFECT: invention provides creating an intranasal spray containing the pharmacologically active ingredients of fexofenadine hydrochloride and ammonium glycyrrhizinate for treating inflammatory and allergic diseases.
1 cl, 1 tbl, 1 ex
Authors
Dates
2020-11-11—Published
2019-12-02—Filed